Front Range Biosciences

Front Range Biosciences is a biotechnology startup founded in 2015 with the mission to revolutionize plant cultivation. The company's slogan, "We’re growing more than the world’s next crop. We’re growing a better future," encapsulates its commitment to innovation. Front Range Biosciences addresses significant challenges in plant growing, including expense, risk, safety, and lack of innovation through cutting-edge scientific tools and techniques. Their offerings include tissue culturing, genetic assays, and marker assisted breeding, which enhance profitability, safety, and innovation in crop cultivation. Front Range Biosciences leverages its team of PhD bioscientists, MIT MBAs, and DuPont plant experts to develop new plant strains with high commercial value and resistance to pathogens. The company recently secured a Venture Round investment on 27 August 2020 from KEY Investment Partners, emphasizing investor confidence in its potential. With a focus on agriculture and biotechnology, the United States-based company is well-positioned in a niche market with little professional competition. Front Range Biosciences boasts a strong IP portfolio and a strategic licensing approach, setting it apart as a vertically integrated biotech company. The company's innovative approach and the backing of KEY Investment Partners bode well for its future, as it aims to usher in a new era of modern plant breeding and cultivation.